Correspondence to editorial 1 on “Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: nationwide cohort study with genetic risk analysis”
Fields of Study & Subjects
Liver Disease Diagnosis and Treatment
Hepatocellular Carcinoma Treatment and Prognosis
Inflammatory mediators and NSAID effects
Publication details
- Journal / source
- Clinical and Molecular Hepatology
- Volume
- 32
- Issue
- 3
- Pages
- e378–e380
- Publication date
- 27 January 2026
- Language
- EN